author-photo

Linda R. Duska

University of Virginia
Harvard University
University of Virginia Health System

273

Papers

4087

Citations

Citation Trend

Filter By

Papers (273) Sort By

Journal Conference Others

Abstract PO036: Patients with recurrent epithelial endometrial cancers (EEC) and Wnt signaling alterations demonstrated greater clinical benefit when treated with DKN-01 monotherapy

2021
Show All
- Source
- Cite
- Save
Citations (0)
Treatment patterns and outcomes among patients with microsatellite stable (MSS) advanced endometrial cancer in the United States: Endometrial Cancer Health Outcomes (ECHO) retrospective chart review Study.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
76P Analysis of antitumor activity of dostarlimab by tumor mutational burden (TMB) in patients (pts) with endometrial cancer (EC) in the GARNET trial

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Phase 1/2 first-in-human (FIH) study of CPI-0209, a novel small molecule inhibitor of enhancer of zeste homolog 2 (EZH2) in patients with advanced tumors.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
531 A Phase 1b multi-tumor cohort study of cabozantinib plus atezolizumab in advanced solid tumors: results of the triple-negative breast cancer, ovarian cancer, and endometrial cancer cohorts

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Post hoc analyses of GOG 9923: Does BRCA status affect toxicities?: An NRG oncology study.

2021 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Interim analysis of the immune-related endpoints of the mismatch repair deficient (dMMR) and proficient (MMRp) endometrial cancer cohorts from the GARNET study

2021 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Immune profiling of advanced, recurrent metastatic endometrial cancer using high-dimensional time-of-flight mass cytometry (CyTOF)

2021 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
261 ENGOT-cx11/GOG 3047/KEYNOTE-A18: phase 3 randomized study of pembrolizumab + chemoradiotherapy for high-risk locally advanced cervical cancer

2021
Show All
- Source
- Cite
- Save
Citations (0)
A surgical window trial evaluating medroxyprogesterone acetate with or without entinostat in endometrial cancer and validation of biomarkers of cellular response: An NRG Oncology study

2021 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (1)